Compounds of formula (I):
1
and their salts, solvates, hydrates and prodrugs are useful PCP inhibitors, processes for making the same, compositions comprising the same, and methods of treating a PCP-mediated condition or disease using the same.
3-HETEROCYCLYLPROPANOHYDROXAMIC ACID AS PROCOLLAGEN C-PROTEINASE INHIBITORS
申请人:Pfizer Limited
公开号:EP1373264A1
公开(公告)日:2004-01-02
US6821972B2
申请人:——
公开号:US6821972B2
公开(公告)日:2004-11-23
[EN] 3-HETEROCYCLYLPROPANOHYDROXAMIC ACID AS PROCOLLAGEN C-PROTEINASE INHIBITORS<br/>[FR] ACIDE 3-HETEROCYCLYLPROPANOHYDROXAMIQUE EN TANT QU'INHIBITEUR DE PROCOLLAGENE C-PROTEINASE
申请人:PFIZER LTD
公开号:WO2002079200A1
公开(公告)日:2002-10-10
Compounds of compounds of formula (I) and their salts, solvates and prodrugs, wherein the substituents are as defined herein, are Procollagen C-proteinase inhibitors for the treatment of scars.
Sato, Nobuhiro; Shimomura, Yuji; Ohwaki, Yoshie, Journal of the Chemical Society. Perkin transactions I, 1991, # 11, p. 2877 - 2882